Literature DB >> 20167270

Understanding the structure and stability of paclitaxel nanocrystals.

Jiexin Deng1, Leaf Huang, Feng Liu.   

Abstract

Previously, PTX/Pluronic F127 nanocrystals were prepared in our laboratory using the stabilization of nanocrystals (SNC) method. For PTX nanocrystals, dosages could be increased to yield improved antitumor activity over Taxol without incidence of acute toxicity. The objectives of this current study are to further understand the structure and stability of PTX nanocrystals. More Pluronic F127 surfactant was added in the formulation to attempt to further stabilize the nanocrystals against thermal induced aggregation. However, this resulted in formation of micelles that worsened the stability of nanocrystals. The F127 desorption experiment suggested different surfactant adsorption affinity to nanocrystal surface below and above the CMC. Below the CMC monomers bound to nanocrystal surface with high affinity, but above the CMC low affinity surfactant aggregates readily left the surface upon dilution. At higher temperature the tendency of F127 micellization is enhanced due to drastically lower CMC. Consequently, at 37 degrees C there was F127 desorption even for nanocrystals prepared with low amounts of F127 (1:5 (w/w) PTX/F127). To improve the stability of nanocrystals, re-nanonization by incubation-sonication procedure was used to disrupt the preferred crystal growth pattern of PTX. Furthermore, we have demonstrated that a higher heating temperature (45 degrees C vs. 37 degrees C) used in the incubation-sonication procedure was able to provide even better nanocrystal stability for long periods of incubation time. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167270      PMCID: PMC3685190          DOI: 10.1016/j.ijpharm.2010.02.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  20 in total

1.  Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  1999-08

2.  Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide.

Authors:  C Jacobs; O Kayser; R H Müller
Journal:  Int J Pharm       Date:  2000-03-10       Impact factor: 5.875

3.  Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization.

Authors:  G C Na; H J Stevens; B O Yuan; N Rajagopalan
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

4.  In vitro and in vivo antitumor activity of oridonin nanosuspension.

Authors:  Haiyan Lou; Xiumei Zhang; Lei Gao; Feifei Feng; Juying Wang; Xinbing Wei; Zongqin Yu; Dianrui Zhang; Qiang Zhang
Journal:  Int J Pharm       Date:  2009-06-27       Impact factor: 5.875

5.  Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.

Authors:  E Merisko-Liversidge; P Sarpotdar; J Bruno; S Hajj; L Wei; N Peltier; J Rake; J M Shaw; S Pugh; L Polin; J Jones; T Corbett; E Cooper; G G Liversidge
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

6.  Histamine release by contrast media.

Authors:  E C Lasser; A Walters; S R Reuter; J Lang
Journal:  Radiology       Date:  1971-09       Impact factor: 11.105

Review 7.  Paclitaxel and its formulations.

Authors:  Anil K Singla; Alka Garg; Deepika Aggarwal
Journal:  Int J Pharm       Date:  2002-03-20       Impact factor: 5.875

8.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel.

Authors:  Sang Cheon Lee; Chulhee Kim; Ick Chan Kwon; Hesson Chung; Seo Young Jeong
Journal:  J Control Release       Date:  2003-05-20       Impact factor: 9.776

9.  Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.

Authors:  Srinivas Ganta; James W Paxton; Bruce C Baguley; Sanjay Garg
Journal:  Int J Pharm       Date:  2008-09-21       Impact factor: 5.875

10.  The effects of Pluronic block copolymers on the aggregation state of nystatin.

Authors:  Scott R Croy; Glen S Kwon
Journal:  J Control Release       Date:  2004-03-05       Impact factor: 9.776

View more
  25 in total

1.  Vitamin E reverses multidrug resistance in vitro and in vivo.

Authors:  Jingling Tang; Qiang Fu; Yongjun Wang; Kelly Racette; Dun Wang; Feng Liu
Journal:  Cancer Lett       Date:  2013-04-23       Impact factor: 8.679

2.  Preparation of Nanocrystals for Insoluble Drugs by Top-Down Nanotechnology with Improved Solubility and Bioavailability.

Authors:  Xun Zhang; Zhiguo Li; Jing Gao; Zengming Wang; Xiang Gao; Nan Liu; Meng Li; Hui Zhang; Aiping Zheng
Journal:  Molecules       Date:  2020-02-28       Impact factor: 4.411

3.  Hyaluronic Acid Layer-By-Layer (LbL) Nanoparticles for Synergistic Chemo-Phototherapy.

Authors:  Juan Zhao; Zhuoya Wan; Chuchu Zhou; Qin Yang; Jianxia Dong; Xu Song; Tao Gong
Journal:  Pharm Res       Date:  2018-08-24       Impact factor: 4.200

4.  Key structure of brij for overcoming multidrug resistance in cancer.

Authors:  Jingling Tang; Yongjun Wang; Dun Wang; Yuhua Wang; Zhenghong Xu; Kelly Racette; Feng Liu
Journal:  Biomacromolecules       Date:  2013-01-24       Impact factor: 6.988

5.  RNA-based micelles: A novel platform for paclitaxel loading and delivery.

Authors:  Yi Shu; Hongran Yin; Mehdi Rajabi; Hui Li; Mario Vieweger; Sijin Guo; Dan Shu; Peixuan Guo
Journal:  J Control Release       Date:  2018-02-14       Impact factor: 9.776

6.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18

7.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

8.  Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals.

Authors:  Sheryhan F Gad; Joonyoung Park; Ji Eun Park; Gihan N Fetih; Sozan S Tous; Wooin Lee; Yoon Yeo
Journal:  Mol Pharm       Date:  2018-01-29       Impact factor: 4.939

9.  Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation.

Authors:  Dalia A Gaber
Journal:  Int J Nanomedicine       Date:  2020-06-17

10.  Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.

Authors:  Yonglu Wang; Xueming Li; Liyao Wang; Yuanlong Xu; Xiaodan Cheng; Ping Wei
Journal:  Int J Nanomedicine       Date:  2011-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.